Mosaic ImmunoEngineering Competitors and Similar CompaniesClear all

Mosaic ImmunoEngineering's competitors and similar companies include Senda Biosciences, NextCure and Bolt Biotherapeutics.
Mosaic ImmunoEngineering
Mosaic ImmunoEngineering
Mosaic ImmunoEngineering (formerly known as Patriot Scientific Corporation) is a biotechnology company focused on bridging immunology and engineering to develop immunotherapies to treat and prevent cancer and infectious diseases.
Senda Biosciences
Senda Biosciences
Senda Biosciences (formerly known as Kintai Therapeutics) is a company developing a platform that deconstructs nature-provided codes for therapeutic purposes.
NextCure
NextCure
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
Bolt Biotherapeutics
Bolt Biotherapeutics
Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
Founding Date
Founding Date
1987
Founding Date
2017
Founding Date
2015
Founding Date
2015
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Carlsbad, US HQ
Locations
Cambridge, US HQ
Locations
Beltsville, US HQ
Locations
Redwood City, US HQ
Employees
Employees
1
Employees
16
Employees
N/A
Employees
5248% decrease
Valuation ($)
Valuation ($)
6.5 m
Valuation ($)
N/A
Valuation ($)
39.2 m
Valuation ($)
25.6 m

Financial

Net income
Net income
($687.8k) (FY, 2025)
Net income
N/A
Net income
($55.8m) (FY, 2025)
Net income
($33.4m) (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 160m
Total funding raised
$ 177.5m
For sources of this data, please see the company profile

View Company Profiles

Senda Biosciences
HQ
Cambridge, US

Senda Biosciences (formerly known as Kintai Therapeutics) is a company developing a platform that deconstructs nature-provided codes for therapeutic purposes.

View company
NextCure
HQ
Beltsville, US

NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.

View company
Bolt Biotherapeutics
HQ
Redwood City, US
Employees
52↓ 48% decrease

Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.

View company